U.S. markets closed

GenMark Diagnostics: 1Q Earnings Snapshot

CARLSBAD, Calif. (AP) _ GenMark Diagnostics Inc. (GNMK) on Monday reported a loss of $7 million in its first quarter.

The Carlsbad, California-based company said it had a loss of 12 cents per share. Losses, adjusted for non-recurring costs, came to 4 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The molecular diagnostics company posted revenue of $38.7 million in the period.

GenMark Diagnostics expects full-year revenue in the range of $120 million to $130 million.

GenMark Diagnostics shares have more than doubled since the beginning of the year. In the final minutes of trading on Monday, shares hit $11.74, a climb of 51% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GNMK at https://www.zacks.com/ap/GNMK